Brittaney A Leeper

5PUBLICATIONS
104CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 08, 2025
Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors.

Elliott J Brea, Simon Baldacci, Neil Savage

|Apr 08, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin.

Karuna Mittal, Garrett W Cooper, Benjamin P Lee

|Oct 11, 2023
The BRD4-NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma.

R Taylor Durall, Julianna Huang, Luke Wojenski

|Sep 29, 2023
Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma.

Adrian Marino-Enriquez, Jan Philipp Novotny, Doga C Gulhan

|Sep 25, 2023
EZH2 Cooperates with BRD4-NUT to Drive NUT Carcinoma Growth by Silencing Key Tumor Suppressor Genes.

Yeying Huang, R Taylor Durall, Nhi M Luong

Pageof 1